Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 144481-98-1
2. Landiolol Hcl
3. Ono 1101 Hydrochloride
4. Ono-1101 Hydrochloride
5. Landiolol Related Impurity 4
6. ((s)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((s)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate Hydrochloride
7. G8hq634y17
8. Ldll600
9. Landiolol (hydrochloride)
10. Dsstox_cid_28531
11. Dsstox_rid_82803
12. Dsstox_gsid_48605
13. [(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2s)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;hydrochloride
14. Landiolol Hydrochloride (jan)
15. Landiolol Hydrochloride [jan]
16. ((s)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((s)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate Hcl
17. Cas-144481-98-1
18. Ncgc00182709-01
19. Ncgc00182709-02
20. Onoact
21. Unii-g8hq634y17
22. Onoact (tn)
23. Landiolol Hydrochloride [usan]
24. Chembl2362410
25. Dtxsid3048605
26. Chebi:31760
27. Landiolol Hydrochloride [mi]
28. Tox21_112940
29. Tox21_113021
30. Mfcd01937430
31. S5540
32. Akos025311253
33. Tox21_113021_1
34. Ccg-269982
35. Hy-100607a
36. Landiolol Hydrochloride [mart.]
37. Landiolol Hydrochloride [who-dd]
38. Ncgc00182709-03
39. Ac-22604
40. As-17684
41. Benzenepropanoic Acid, 4-(2-hydroxy-3-((2-((4-morpholinylcarbonyl)amino)ethyl)amino)propoxy)-, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl Ester, (s-(r*,r*))-, Hydrochloride
42. Landiolol Hydrochloride, >=98% (hplc)
43. Cs-0019761
44. L0296
45. D01847
46. A808219
47. Q27278937
48. 4-((s)-2-hydroxy-3-((2-((morpholinocarbonyl)amino)ethyl)amino)propoxy)benzenepropanoic Acid ((s)-2,2-dimethyl-1,3-dioxolane-4alpha-yl)methyl Hydrochloric Acid
49. Benzenepropanoic Acid, 4-[(2s)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl Ester, Hydrochloride (1:1)
| Molecular Weight | 546.1 g/mol |
|---|---|
| Molecular Formula | C25H40ClN3O8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 545.2503929 g/mol |
| Monoisotopic Mass | 545.2503929 g/mol |
| Topological Polar Surface Area | 128 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 666 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Treatment of supraventricular arrhythmias

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
71
PharmaCompass offers a list of Landiolol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Landiolol Hydrochloride manufacturer or Landiolol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Landiolol Hydrochloride manufacturer or Landiolol Hydrochloride supplier.
PharmaCompass also assists you with knowing the Landiolol Hydrochloride API Price utilized in the formulation of products. Landiolol Hydrochloride API Price is not always fixed or binding as the Landiolol Hydrochloride Price is obtained through a variety of data sources. The Landiolol Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Landiolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Landiolol, including repackagers and relabelers. The FDA regulates Landiolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Landiolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Landiolol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Landiolol supplier is an individual or a company that provides Landiolol active pharmaceutical ingredient (API) or Landiolol finished formulations upon request. The Landiolol suppliers may include Landiolol API manufacturers, exporters, distributors and traders.
click here to find a list of Landiolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Landiolol DMF (Drug Master File) is a document detailing the whole manufacturing process of Landiolol active pharmaceutical ingredient (API) in detail. Different forms of Landiolol DMFs exist exist since differing nations have different regulations, such as Landiolol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Landiolol DMF submitted to regulatory agencies in the US is known as a USDMF. Landiolol USDMF includes data on Landiolol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Landiolol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Landiolol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Landiolol Drug Master File in Japan (Landiolol JDMF) empowers Landiolol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Landiolol JDMF during the approval evaluation for pharmaceutical products. At the time of Landiolol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Landiolol suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Landiolol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Landiolol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Landiolol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Landiolol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Landiolol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Landiolol suppliers with NDC on PharmaCompass.
Landiolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Landiolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Landiolol GMP manufacturer or Landiolol GMP API supplier for your needs.
A Landiolol CoA (Certificate of Analysis) is a formal document that attests to Landiolol's compliance with Landiolol specifications and serves as a tool for batch-level quality control.
Landiolol CoA mostly includes findings from lab analyses of a specific batch. For each Landiolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Landiolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Landiolol EP), Landiolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Landiolol USP).